技术

抗体（Antibodies）

<2019 Mizui, T., et al. (2019). Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia. Journal of Psychiatric Research doi: 10.1016/j.jpsychires.2019.03.024 [anti-human proBDNF a...

基因组编辑工具（CRISPR & TALEN）

>2020 Frendewey, D., et al. (2020). METHODS AND COMPOSITIONS FOR TARGETED GENETIC MODIFICATION USING PAIRED GUIDE RNAS. United States Patent Application 20200002730 [GeneHero™ sgRNA clones targeting Lrp5] Zh...

荧光标记和检测技术（Fluorescent Labeling and Detection）

>2020 Luo, Q., et al. (2020). TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma. Cell Reports doi: 10.1016/j.celrep.2019.12.017 [TUNEL Andy Fluor...

预制稳转株（Stable cell lines）

< 2020 Kasper, S.H., et al. (2020). Colorectal cancer-associated anaerobic bacteria proliferate in tumor spheroids and alter the microenvironment. Scientific Reports doi: 10.1038/s41598-020-62139-z [GFP labeled...

转染试剂（Transfection reagents）

>2020 Ding, W., et al. (2020). Positive feedback loop SP1/SNHG1/miR-199a-5p promotes the malignant properties of thyroid cancer. Biochemical and Biophysical Research Communications doi: 10.1016/j.bbrc.2019.11.075 [E...

荧光素酶检测（Luciferase Assays）

>2020 Sanchez, H.N., et al. (2020). B cell-intrinsic epigenetic modulation of antibody responses by dietary fiber-derived short-chain fatty acids. Nature Communications doi: 10.1038/s41467-019-13603-6 [Luc‐Pair...

重组蛋白

<2016 Zhou, Y., et al. (2016) Competitive profiling of celastrol targets in human cervical cancer HeLa cells via quantitative chemical proteomics . Molecular Biosystems 10.1039/C6MB00691D [Recombinant human GSTO1 pr...

启动子报告克隆（Promoter Reporter Clones）

< 2020 McCutcheon, S., et al. (2020). Apoptotic osteocytes induce RANKL production in bystanders via purinergic signaling and activation of pannexin channels. Journal of Bone and Mineral Research doi: 10.1002/jbmr.3...

qPCR Arrays

Huang, L. et al. (2012) Downregulation of Six MicroRNAs Is Associated with Advanced Stage, Lymph Node Metastasis and Poor Prognosis in Small Cell Carcinoma of the Cervix. PLoS ONE 7(3): e33762. doi:10.1371/journal.pone.0033762....

分子生物学试剂

< 2016 Bid, HK., et al. (2016). The Bromodomain BET inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma. Molecular Cancer Therapeutics,Published ...

基因下调—shRNA

< 2019 Song, N., et al. (2019). Knockdown of high mobility group box 3 impairs cell viability and colony formation but increases apoptosis in A549 human non‑small cell lung cancer cells. Oncology eports doi: 10.3892/ol.2...

miRNA解决方案

<2020 Wei, Q., et al. (2020). MicroRNA-101-3p inhibits fibroblast-like synoviocyte proliferation and inflammation in rheumatoid arthritis by targeting PTGS2. Bioscience Reports doi: 10.1042/BSR20191136 [All-in-...

GeneCopoeia miRNA 全面解决方案 — 全面广泛的功能分析和检测工具帮您彻底了解miRNA（检测和定量细胞中的miRNA）

研究miRNA的作用，或验证假设的目标miRNA，GeneCopoeia提供正确的解决方法。GeneCopoeia miRNA 研究工具帮助您设计有效实验回答您的疑问。某个特异miRNA的调节功能是怎样实现的? miRNA表达量的变化会直接或间接导致癌症或其他疾病吗? 如...

Gateway克隆技术原理

Gateway克隆技术基于已研究的非常清楚的λ噬菌体位点特异重组系统，使用Int (integrase)和 IHF (Integration Host Factor) 催化重组反应， attB和attP位点的重组反应会生成attL和attR...

Gateway® Technology

Gateway®克隆技术的基础是 λ噬菌体的位点特异性重组反应，一种保存遗传信息的有效的生化途径（见图1）。与传统的需要DNA限制性内切酶、DNA连接酶、凝胶电泳和DNA片段纯化等多个步骤的繁琐亚克隆方法相比，该方法只需一步生化反...

OmicsLink™ 克隆的应用及与全长转录本cDNA克隆的区别

可以在E.coli 细胞中表达蛋白可以通过反向转染在哺乳动物细胞中表达蛋白可以在体外无细胞体系中表达蛋白表达带有标签的蛋白，可用于纯化和下游分析产生原位杂...

qPCR验证引物与试剂盒

构建目的表达克隆的高效方法

ORFEXPRESS™-Shuttle Clone与目的载体attL和attR位点的重组反应可以生成目的表达克隆。这种特异性极高的重组反应不会导致LXR位点间碱基的增加或删除。在 ORFEXPRESS™-Shuttle Clone中，起始...

慢病毒产品与服务

>2020 McCutcheon, S., et al. (2020). Apoptotic osteocytes induce RANKL production in bystanders via purinergic signaling and activation of pannexin channels. Journal of Bone and Mineral Research doi: 10.1002/jbmr.39...

ORF/cDNA克隆

< 2020 Xia, X., et al.. (2020). Molecular basis and restoration of function deficiencies of Kv7.4 variants associated with inherited hearing loss. Hearing Research doi: 10.1016/j.heares.202...